IthaID: 2548
Names and Sequences
Functionality: | Globin gene causative mutation | Pathogenicity: | N/A |
---|---|---|---|
Common Name: | Inv-Del English V | HGVS Name: | NC_000011.10:g.5194460_5253454invdel5194460_5194542del5253454_5375965 |
Hb Name: | N/A | Protein Info: | N/A |
Also known as:
Comments: This structural variant involved a 59.0 kb inversion encompassing HBG2 exon 3, HBG1, HBD, HBB, and OR51V1, juxtaposed by a deletion of 122.6 kb including 82 bp of the inverted sequence, HBG2 exon 1 and 2, HBE, and the β-locus control region.
We follow the HGVS sequence variant nomenclature and IUPAC standards.
External Links
Phenotype
Hemoglobinopathy Group: | Thalassaemia |
---|---|
Hemoglobinopathy Subgroup: | εγδβ-thalassaemia |
Allele Phenotype: | (εGγAγδβ)0 |
Associated Phenotypes: |
Haemolytic anaemia [HP:0001878] Ineffective erythropoiesis [HP:0010972] |
Other details
Type of Mutation: | Deletion |
---|---|
Ethnic Origin: | English |
Molecular mechanism: | N/A |
Inheritance: | Recessive |
DNA Breakpoint Determined: | Yes |
In silico pathogenicity prediction
Note:
The impact thresholds provided in this section are based on the analyses performed in Tamana et.al. For any given tool, the impact thresholds defined for the set of variants with the same effect on function as the variant examined, are preferred over those defined for the full dataset.
Publications / Origin
- Shooter C, Rooks H, Thein SL, Clark B, Next Generation Sequencing Identifies a Novel Rearrangement in the HBB Cluster Permitting to-the-Base Characterization., Hum. Mutat. , 36(1), 142-50, 2015
Created on 2015-01-12 12:05:27,
Last reviewed on 2021-09-29 09:56:20 (Show full history)
A/A | Date | Curator(s) | Comments |
---|---|---|---|
1 | 2015-01-12 12:05:27 | The IthaGenes Curation Team | Created |
2 | 2021-09-29 09:56:20 | The IthaGenes Curation Team | Reviewed. HGVS name corrected. |
Disclaimer: The information on this website is provided as an information resource only
and must not to be used as a substitute for professional diagnosis and treatment.
The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment,
diagnosis or any other information, services or products that an individual obtains through this website.
IthaGenes was last updated on 2024-11-20 13:24:07